A Case of Single-lung Transplant in a Patient with <i>Mycobacterium avium</i> Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension-Reference-Cited by-同舟云学术

A Case of Single-lung Transplant in a Patient with <i>Mycobacterium avium</i> Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension

Published:2024 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ozeki Taichi¹,Higo Hisao²,Omori Hiroki²,Mori Shunta²,Tanaka Shin³,Makimoto Go²,Ninomiya Kiichiro⁴,Taniguchi Akihiko⁵,Fujii Masanori²,Miyoshi Kentaro⁶,Rai Kammei⁷,Ichihara Eiki⁸,Ohashi Kadoaki²,Sugimoto Seiichiro³,Hotta Katsuyuki⁷,Tabata Masahiro⁸,Toyooka Shinichi⁶,Maeda Yoshinobu¹,Miyahara Nobuaki⁹

Affiliation:

1. Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan

2. Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan

3. Organ Transplant Center, Okayama University Hospital, Japan

4. Center for Comprehensive Genomic Medicine, Okayama University Hospital, Japan

5. Department of Respiratory Medicine, National Hospital Organization Fukuyama Medical Center, Japan

6. Department of Thoracic Surgery, Okayama University Hospital, Japan

7. Center for Innovative Clinical Medicine, Okayama University Hospital, Japan

8. Center for Clinical Oncology, Okayama University Hospital, Japan

9. Department of Medical Technology, Okayama University Graduate School of Health Sciences, Japan

Publisher

Japanese Society of Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3854-24/_pdf

Reference16 articles.

1. 1. Chalermskulrat W, Sood N, Neuringer IP, et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 61: 507-513, 2006.

2. 2. Qvist T, Pressler T, Thomsen VO, Skov M, Iversen M, Katzenstein TL. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Transplant Proc 45: 342-345, 2013.

3. 3. Lobo LJ, Chang LC, Esther CR Jr, Gilligan PH, Tulu Z, Noone PG. Lung transplantationoutcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections. Clin Transplant 27: 523-529, 2013.

4. 4. Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplantationcandidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 40: 1349-1379, 2021.

5. 5. Griffith DE, Eagle G, Thomson R, et al. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med 198: 1559-1569, 2018.